
Overview
Dr. Vyas was drawn to Oncology because of the opportunity to compassionately guide patients through the challenges of facing cancer. He prides himself on clear communication and achieving the best possible quality of life for his patients. Dr. Vyas has a particular interest in immunotherapy and targeted therapies and is triple-boarded in Medical Oncology, Hematology, and Internal Medicine. Originally from Northern California, Dr. Vyas lived in Boston before calling Central Texas home. He enjoys spending time with his wife and young daughter, as well as playing tennis, cooking and listening to live music. Dr. Vyas has been recognized as a Top Doc 2023, 2024, and 2025 by Austin Monthly Magazine. Winners are nominated by their peers as among the best in their region/nation in their medical specialty.
Dr. Vyas is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Lung Cancer.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300A University Blvd, Round Rock, TX 78665
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Baylor Scott & White Cancer Center - Round Rock
Dr. Christal Murray is a board-certified physician, specializing in hematology and oncology. Her professional interests include breast cancer, clinical trials, benign hematology and malignant hematology. She is passionate about working together with her patients, moving toward the same goal. She believes the rapidly changing landscape of oncology is exciting and challenging, and enjoys witnessing how these changes and innovations directly impact patients’ lives. In her spare time, Dr. Murray enjoys spending time with family, reading, running, knitting and traveling. Dr. Murray has been recognized as a Top Doc 2020, 2021, 2023, 2024, and 2025 by Austin Monthly Magazine. Winners are nominated by their peers as among the best in their region/nation in their medical specialty. Dr. Murray has been selected as a 2023 Super Doc by Texas Monthly magazine. The honor recognizes providers who have attained a high degree of peer recognition and professional achievement. Dr. Murray is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.
Baylor Scott & White Vasicek Cancer Treatment Center - Temple
Dr. Bhat is a board-certified hematologist/ medical oncologist who has formed a niche in breast oncology. She joined BSW at Temple's main campus in 2011 soon after completing her fellowship, and her medical practice mostly consists of breast cancer patients. She also supervises the trainee fellows in their continuity clinic and is one of the core faculty in Baylor Scott & White's 3-year hem-oncology fellowship program. Dr. Bhat has been the site director of NSABP and is currently the chair of the breast tumor board, a weekly interdisciplinary case discussion conference, where NCCN guidelines and optimal treatment options for all their breast cancer patients are discussed. She is passionate about taking care of breast cancer patients and believes in providing them with a comprehensive, yet personalized care plan when it comes to their cancer. Their clinic offers several state-of-the-art treatments like novel chemotherapies, biotherapies, targeted therapies, and immunotherapies. In addition to these standard treatments, she strives to bring on relevant and pertinent clinical trials that would benefit our breast cancer patients. She frequently offers second and third-opinion consults on complicated cases that are referred from our peripheral clinics. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, Bone Marrow Aspiration, and Endoscopy.
Sripriya Santhanam is a Hematologist and an Oncologist in Temple, Texas. Dr. Santhanam is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Lung Cancer, Pleuropulmonary Blastoma, and Inflammatory Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Childhood Iron Deficiency Anemia
- Colorectal CancerDr. Vyas isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Vyas isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Vyas isAdvanced. Learn about Familial Colorectal Cancer.
- Iron Deficiency AnemiaDr. Vyas isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acquired HemophiliaDr. Vyas isExperienced. Learn about Acquired Hemophilia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Vyas isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Vyas isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Vyas isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Vyas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Vyas isExperienced. Learn about Agranulocytosis.


